Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.59 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
| ▸ | YARS1 | P54577 | 2/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31710294 | 1.00 | LNPEP (0.59) | LNPEPERAP2NAALAD2FOLH1NPY1R | |
| SCHEMBL30090915 | 0.94 | LNPEP (0.64) | LNPEPERAP2NPY1RNPY2RNPY4R | |
| SCHEMBL31710009 | 0.94 | NAALAD2 (0.58) | LNPEPERAP2NAALAD2FOLH1NPY1R | |
| SCHEMBL285712 | 0.94 | NAALAD2 (0.58) | LNPEPERAP2NAALAD2FOLH1NPY1R | |
| SCHEMBL29854734 | 0.94 | NAALAD2 (0.58) | LNPEPERAP2NAALAD2FOLH1NPY1R | |
| SCHEMBL29693799 | 0.94 | NAALAD2 (0.58) | LNPEPERAP2NAALAD2FOLH1NPY1R | |
| SCHEMBL4417821 | 0.94 | LNPEP (0.59) | LNPEPERAP2NAALAD2NPY1RNPY2R | |
| SCHEMBL4417844 | 0.94 | LNPEP (0.59) | LNPEPERAP2NAALAD2NPY1RNPY2R | |
| SCHEMBL30178189 | 0.93 | LNPEP (0.51) | LNPEPERAP2NAALAD2NPY1RNPY2R | |
| SCHEMBL30974007 | 0.92 | ERAP2 (0.52) | LNPEPERAP2NAALAD2NPY1RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676599-A1 | IMPROVED BISPECIFIC ANTI-TUMOR ANTIGEN/ANTI-HSG ANTIBODIES FOR PRE-TARGETING OF HYPERPROLIFERATIVE DISORDERS | OncoOne Research & Development GmbH (AT) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024184171-A1 | IMPROVED BISPECIFIC ANTI-TUMOR ANTIGEN/ANTI-HSG ANTIBODIES FOR PRE-TARGETING OF HYPERPROLIFERATIVE DISORDERS | ONCOONE RESEARCH & DEVELOPMENT GMBH (AT) | 2024-09-12 | — | — | WO | disclosed |